發(fā)布時(shí)間：2018-04-01 20:14

  本文選題：急性痛風(fēng)性關(guān)節(jié)炎　切入點(diǎn)：金黃活血散　出處：《山西省中醫(yī)藥研究院》2017年碩士論文

【摘要】：目的:本研究通過(guò)觀察金黃活血散外敷治療濕熱蘊(yùn)結(jié)型急性痛風(fēng)性關(guān)節(jié)炎的臨床療效,初步探討該藥針對(duì)患病關(guān)節(jié)的鎮(zhèn)痛消腫作用以及降低血尿酸和相關(guān)炎癥指標(biāo)的效果,并對(duì)其安全性進(jìn)行評(píng)價(jià),為該藥的進(jìn)一步推廣應(yīng)用提供依據(jù)。方法:本研究設(shè)計(jì)遵循平行對(duì)照、隨機(jī)化原則,選取2015年1月~2016年12月期間就診于山西省中醫(yī)院疼痛科和風(fēng)濕科住院部的患者,納入患者均符合西醫(yī)診斷標(biāo)準(zhǔn)和中醫(yī)病證診斷標(biāo)準(zhǔn),共納入患者96例,隨機(jī)分為治療組(48例)和對(duì)照組(48例)。治療組外敷金黃活血散,對(duì)照組外敷扶他林(雙氯芬酸二乙胺乳膠劑),兩組患者每日敷藥2次,治療10天。觀察金黃活血散在改善關(guān)節(jié)疼痛、腫脹以及恢復(fù)關(guān)節(jié)功能等方面的作用,同時(shí)觀察其降低血尿酸和相關(guān)炎癥指標(biāo)的作用。分別觀察并記錄兩組患者治療前后中醫(yī)證候評(píng)分、疼痛VAS評(píng)分,以及實(shí)驗(yàn)室指標(biāo):血尿酸(UA)、血清C反應(yīng)蛋白(CRP)、紅細(xì)胞沉降率(ESR)的變化,同時(shí)注意監(jiān)測(cè)可能出現(xiàn)的不良反應(yīng)。采用SPSS23.0統(tǒng)計(jì)軟件對(duì)全部數(shù)據(jù)進(jìn)行分析處理。結(jié)果:1.兩組臨床總療效比較:經(jīng)過(guò)為期10天的治療,治療組總有效率為87.23%,對(duì)照組總有效率為76.60%,通過(guò)比較兩組之間差異有統(tǒng)計(jì)學(xué)意義(P0.05),治療組臨床總療效優(yōu)于對(duì)照組。2.兩組中醫(yī)證候評(píng)分比較:治療后兩組患者中醫(yī)證候評(píng)分較治療前均有大幅度的降低,通過(guò)比較兩組之間差異有統(tǒng)計(jì)學(xué)意義(P0.01),治療組緩解各項(xiàng)關(guān)節(jié)主癥及次癥效果優(yōu)于對(duì)照組。3.兩組疼痛VAS評(píng)分比較:治療后兩組患者疼痛評(píng)分較治療前均有明顯的下降,通過(guò)比較兩組之間差異有統(tǒng)計(jì)學(xué)意義(P0.01),治療組緩解關(guān)節(jié)疼痛情況優(yōu)于對(duì)照組。4.兩組實(shí)驗(yàn)室指標(biāo)比較:治療后兩組UA、CRP、ESR均較治療前有明顯的降低,治療后組間比較,UA差別無(wú)統(tǒng)計(jì)學(xué)意義(P0.05),CRP、ESR差別有統(tǒng)計(jì)學(xué)意義(P0.05),CRP、ESR治療后組間比較無(wú)臨床意義,兩種治療方案均能有效降低血尿酸和改善炎癥反應(yīng)。5.兩組安全性指標(biāo)比較:兩組患者治療前后進(jìn)行三大常規(guī)、心電圖及肝腎功能比較,均無(wú)明顯異常變化,不良反應(yīng)發(fā)生率比較差別無(wú)統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:通過(guò)臨床觀察,外敷金黃活血散可有效緩解患者關(guān)節(jié)疼痛、紅腫、功能障礙等主要癥狀,且能有效抑制患病關(guān)節(jié)的炎癥反應(yīng),同時(shí)無(wú)明顯不良反應(yīng),在降低血尿酸方面,與扶他林無(wú)明顯差異。因此,運(yùn)用金黃活血散外敷治療急性痛風(fēng)性關(guān)節(jié)炎,臨床療效良好,值得進(jìn)一步推廣應(yīng)用。
[Abstract]:Objective: to observe the clinical efficacy of Jinhuang Huoxue Powder in treating acute gouty arthritis with damp-heat accumulation, and to explore the effect of this medicine on relieving pain and swelling and reducing serum uric acid and related inflammatory indexes.The safety of the drug was evaluated to provide the basis for the further application of the drug.Methods: according to the principle of parallel control and randomization, the patients who were admitted to the Department of pain and Rheumatology of Shanxi traditional Chinese Medicine Hospital from January 2015 to December 2016 were selected.All the patients were in accordance with the diagnostic criteria of western medicine and traditional Chinese medicine. 96 patients were randomly divided into treatment group (n = 48) and control group (n = 48).The treatment group was treated with Jinhuang Huoxue Powder and the control group with Fentalin (diclofenac diethylamine emulsion) twice a day for 10 days.To observe the effect of Jinhuang Huoxue Powder on improving joint pain, swelling and restoring joint function, and to observe the effect of Jinhuang Huoxue Powder on reducing blood uric acid and related inflammatory indexes.To observe and record the changes of TCM syndrome score, pain VAS score and laboratory indexes before and after treatment in two groups: serum uric acid, serum C-reactive protein (CRP), erythrocyte sedimentation rate (ERR), and to monitor the possible adverse reactions.All the data are analyzed and processed by SPSS23.0 software.The result is 1: 1.After 10 days of treatment, the total effective rate of the treatment group was 87.23 and the total effective rate of the control group was 76.60. The difference between the two groups was statistically significant (P 0.05). The total clinical efficacy of the treatment group was better than that of the control group.Comparison of TCM syndromes between the two groups: after treatment, the scores of TCM syndromes in the two groups were significantly decreased compared with those before treatment, and the difference between the two groups was statistically significant (P 0.01). The effect of relieving the main symptoms and secondary symptoms of joints in the treatment group was better than that in the control group (3. 3).Comparison of pain VAS score between the two groups: after treatment, the pain scores of the two groups were significantly lower than those before treatment, the difference between the two groups was statistically significant (P 0.01), the relief of joint pain in the treatment group was better than that in the control group (.4).Comparison of laboratory indexes between the two groups: after treatment, the ESR of UAP was significantly lower than that of before treatment, and there was no significant difference in ESR between the two groups after treatment. There was no significant difference in ESR between the two groups after treatment, and there was no clinical significance between the two groups after treatment.Both can effectively reduce serum uric acid and improve inflammatory response.Comparison of safety indexes between the two groups: before and after treatment, there were no obvious abnormal changes in electrocardiogram and liver and kidney function, and there was no significant difference in the incidence of adverse reactions between the two groups before and after treatment (P 0.05).Conclusion: through clinical observation, application of Jinhuang Huoxue Powder can effectively relieve the main symptoms of joint pain, redness and swelling, dysfunction and so on, and can effectively inhibit the inflammatory reaction of the diseased joint, without obvious adverse reaction, so it can reduce blood uric acid.There was no significant difference between the two groups.Therefore, the application of Jinhuang Huoxue Powder in the treatment of acute gouty arthritis has a good clinical effect and is worth further popularizing.
【學(xué)位授予單位】：山西省中醫(yī)藥研究院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R259

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;扶他林有獎(jiǎng)?wù)魑腫J];中國(guó)實(shí)用內(nèi)科雜志;1996年04期

2 王敘冬;扶他林治療膝關(guān)節(jié)骨性關(guān)節(jié)炎療效觀察[J];鎮(zhèn)江醫(yī)學(xué)院學(xué)報(bào);1997年04期

3 ;扶他林片劑藥品簡(jiǎn)介[J];中國(guó)實(shí)用內(nèi)科雜志;1997年04期

4 陳良;陳銀海;張偉;;扶他林控制耳鼻喉急性感染及手術(shù)后疼痛的臨床觀察[J];中國(guó)城鄉(xiāng)企業(yè)衛(wèi)生;2008年03期

5 張鵬;沈洲;徐福祥;;扶他林乳膠劑治療急性踝扭傷的療效分析[J];醫(yī)學(xué)信息(中旬刊);2010年11期

6 任勇;;扶他林治療耳鼻喉急性感染及術(shù)后疼痛的臨床研究[J];中國(guó)衛(wèi)生產(chǎn)業(yè);2014年13期

7 邢科;武亮;朱玉杰;;扶他林治療57例四肢急慢性疼痛的療效觀察[J];醫(yī)學(xué)信息(中旬刊);2011年09期

8 馮建民,張言鳳,張偉濱;雙氯芬酸鈉緩釋片與扶他林片的臨床效果比較[J];上海醫(yī)藥;1997年09期

9 賈建平;;扶他林乳膠聯(lián)合熱敷緩解疼痛[J];護(hù)理學(xué)雜志;2012年14期

10 黃靜華;;扶他林對(duì)顳下頜關(guān)節(jié)紊亂病疼痛治療的研究[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2012年09期

相關(guān)會(huì)議論文 前1條

1 馬天偉;張國(guó)初;;半導(dǎo)體激光及扶他林乳膠超聲透入法治療顳頜關(guān)節(jié)功能紊亂[A];第四屆全國(guó)康復(fù)治療學(xué)術(shù)大會(huì)論文摘要匯編[C];2004年

相關(guān)重要報(bào)紙文章 前6條

1 本報(bào)記者 王丹 鄭智敏;諾華重兵投入OTC[N];醫(yī)藥經(jīng)濟(jì)報(bào);2004年

2 本報(bào)記者 陳國(guó)東;從運(yùn)動(dòng)型定位到情感訴求[N];醫(yī)藥經(jīng)濟(jì)報(bào);2003年

3 本報(bào)記者 劉侃;疼了，別忍著[N];科技日?qǐng)?bào);2004年

4 李學(xué)梅;北京暫不召回芬必得扶他林[N];北京日?qǐng)?bào);2005年

5 記者 王建新;個(gè)性化用藥 嚴(yán)格掌握用藥適應(yīng)癥[N];中國(guó)消費(fèi)者報(bào);2005年

6 小漁;誰(shuí)為你療傷止痛鏨[N];中國(guó)醫(yī)藥報(bào);2004年

相關(guān)碩士學(xué)位論文 前2條

1 李正興;“易層”貼敷緩解中重度膝骨性關(guān)節(jié)炎患者疼痛的療效研究[D];南京中醫(yī)藥大學(xué);2016年

2 張敏;金黃活血散外敷治療急性痛風(fēng)性關(guān)節(jié)炎的臨床觀察[D];山西省中醫(yī)藥研究院;2017年

，

本文編號(hào)：1697119